Literature DB >> 16441686

The developmental origins of adult disease (Barker) hypothesis.

Hendrina A de Boo1, Jane E Harding.   

Abstract

Many studies have provided evidence for the hypothesis that size at birth is related to the risk of developing disease in later life. In particular, links are well established between reduced birthweight and increased risk of coronary heart disease, diabetes, hypertension and stroke in adulthood. These relationships are modified by patterns of postnatal growth. The most widely accepted mechanisms thought to underlie these relationships are those of fetal programming by nutritional stimuli or excess fetal glucocorticoid exposure. It is suggested that the fetus makes physiological adaptations in response to changes in its environment to prepare itself for postnatal life. These changes may include epigenetic modification of gene expression. Less clear at this time are the relevance of fetal programming phenomena to twins and preterm babies, and whether any of these effects can be reversed after birth. Much current active research in this field will be of direct relevance to future obstetric practice.

Entities:  

Mesh:

Year:  2006        PMID: 16441686     DOI: 10.1111/j.1479-828X.2006.00506.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  164 in total

1.  Recognizing and preventing childhood obesity: Challenging pediatricians with averting this epidemic even in their littlest patients.

Authors:  Diana H Dolinsky; Anna Maria Siega-Riz; Eliana Perrin; Sarah C Armstrong
Journal:  Contemp Pediatr       Date:  2011-01-01

2.  Impact of maternal and paternal preconception health on birth outcomes using prospective couples' data in Add Health.

Authors:  Jennifer L Moss; Kathleen Mullan Harris
Journal:  Arch Gynecol Obstet       Date:  2014-11-04       Impact factor: 2.344

Review 3.  Critical issues in setting micronutrient recommendations for pregnant women: an insight.

Authors:  Cristiana Berti; Tamás Decsi; Fiona Dykes; Maria Hermoso; Berthold Koletzko; Maddalena Massari; Luis A Moreno; Luis Serra-Majem; Irene Cetin
Journal:  Matern Child Nutr       Date:  2010-10       Impact factor: 3.092

4.  Ovine surgical model of uterine space restriction: interactive effects of uterine anomalies and multifetal gestations on fetal and placental growth.

Authors:  Katie M Meyer; Jill M Koch; Jayanth Ramadoss; Pamela J Kling; Ronald R Magness
Journal:  Biol Reprod       Date:  2010-06-23       Impact factor: 4.285

5.  Pregnancy Complications and the Risk of Metabolic Syndrome for the Offspring.

Authors:  Kelli K Ryckman; Kristi S Borowski; Nisha I Parikh; Audrey F Saftlas
Journal:  Curr Cardiovasc Risk Rep       Date:  2013-06

6.  In utero exposure to di-(2-ethylhexyl) phthalate induces testicular effects in neonatal rats that are antagonized by genistein cotreatment.

Authors:  Steven Jones; Annie Boisvert; Sade Francois; Liandong Zhang; Martine Culty
Journal:  Biol Reprod       Date:  2015-08-26       Impact factor: 4.285

Review 7.  Birth Weight and Risk of Cardiovascular Disease Incidence in Adulthood: a Dose-Response Meta-analysis.

Authors:  Reza Mohseni; Shimels Hussien Mohammed; Maryam Safabakhsh; Fatemeh Mohseni; Zahra Sajedi Monfared; Javad Seyyedi; Zahra Noorani Mejareh; Shahab Alizadeh
Journal:  Curr Atheroscler Rep       Date:  2020-04-23       Impact factor: 5.113

Review 8.  Developmental exposure to environmental endocrine disruptors: consequences within the ovary and on female reproductive function.

Authors:  Mehmet Uzumcu; Rob Zachow
Journal:  Reprod Toxicol       Date:  2006-11-06       Impact factor: 3.143

9.  The impact of maternal obesity on maternal and fetal health.

Authors:  Meaghan A Leddy; Michael L Power; Jay Schulkin
Journal:  Rev Obstet Gynecol       Date:  2008

Review 10.  Psychosocial stress in pregnancy and preterm birth: associations and mechanisms.

Authors:  Gabriel D Shapiro; William D Fraser; Martin G Frasch; Jean R Séguin
Journal:  J Perinat Med       Date:  2013-11       Impact factor: 1.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.